Table 2.
Model with dose only | ||||
---|---|---|---|---|
| ||||
Actual dose delivered
|
Intention To Treat
|
|||
b0,TRG1: | −3.928 (−5.787;−2.181) | b0,TRG1: | −3.511 (−5.417;−1.621) | |
b0,TRG2: | −3.079 (−4.865;−1.392) | b0,TRG2: | −2.671 (−4.501;−0.814) | |
b0,TRG3: | 0.085 (−1.591;1.693) | b0,TRG3: | 0.451 (−1.282;2.153) | |
b1: | 0.0427 (0.0153;0.0712) | b1: | 0.0358 (0.0060;0.0648) |
Model with dose, tumour size and N-category
| ||||
---|---|---|---|---|
| ||||
| ||||
Actual dose delivered
|
Intention To Treat
|
|||
b0,TRG1: | −2.634 (−4.836;0.600) | b0,TRG1: | −2.106 (−4.400;0.060) | |
b0,TRG2: | −1.762 (−3.903;0.246) | b0,TRG2: | −1.240 (−3.514;0.856) | |
b0,TRG3: | 1.463 (−0.641;3.404) | b0,TRG3: | 1.949 (−0.281;3.979) | |
b1: | 0.0349 (0.0060;0.0641) | b1: | 0.0268 (−0.0039;0.0580) | |
btumour-size: | −0.0058 (−0.0132;0.0008) | btumour-size: | −0.0061 (−0.0134;0.0008) | |
bN-category: | −0.6252 (−1.3399;0.1449) | bN-category: | −0.6580 (−1.3920;0.1106) |
TRPTRG≤i is the probability of tumour regression of at least grade TRGi. EQD2 is the equivalent average dose to the tumour in 2 Gy fractions. Yvol is the pre-treatment tumour volume, as estimated from the tumour length and diameter on the pre-treatment MRI scan and assuming cylindrical symmetry. YN-category is 0 for clinical N0 patients and 1 for N1-2 patients. The b1 coefficient has the unit of [Gy−1], the btumour-size coefficient the unit of [cm−3]. All other coefficients are dimensionless.